BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16549046)

  • 1. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)].
    Kochan Z; Karbowska J
    Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Rehmannia glutinosa water extraction on insulin resistance and gene expression of resistin in type 2 diabetes mellitus rats].
    Lv XF; Meng QY; Guo XM
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(20):2182-4. PubMed ID: 18306758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the biology and physiology of resistin.
    Adeghate E
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2485-96. PubMed ID: 15526156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones.
    Yki-Järvinen H
    N Engl J Med; 2004 Sep; 351(11):1106-18. PubMed ID: 15356308
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistin.
    McTernan PG; Kusminski CM; Kumar S
    Curr Opin Lipidol; 2006 Apr; 17(2):170-5. PubMed ID: 16531754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
    Murdolo G; Smith U
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-time alcohol intake modifies resistin secretion and expression of resistin gene in adipose tissue.
    Pravdová E; Macho L; Hlavácová N; Ficková M
    Gen Physiol Biophys; 2007 Sep; 26(3):221-9. PubMed ID: 18063850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of thiazolidinediones.
    Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin expression and plasma concentration peak at different times during pregnancy in rats.
    Caja S; Martínez I; Abelenda M; Puerta M
    J Endocrinol; 2005 Jun; 185(3):551-9. PubMed ID: 15930181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
    Blaschke F; Caglayan E; Hsueh WA
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):561-74, ix. PubMed ID: 16959586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin.
    Cohen G; Hörl WH
    Semin Dial; 2009; 22(4):373-7. PubMed ID: 19708984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.